Insilico Medicine has developed a SaaS tool to aid in solving the common pitfalls and overcoming failure in the clinical phase of drug development. InClinico is positioned to support clinical researchers in the biotech and pharmaceutical sector and investors. Clinical scientists in Pharma use inClinico to identify red flags in ongoing clinical trials and suggest corrections that could be made to eliminate the red flags before the first patient is enrolled. InClinico can also be used retrospectively to identify issues from past trials. Both prospective and retrospective use of inClinico can aid clinical trial prioritization and tracking of the competitive landscape. Investors use inClinico to identify companies that are likely to be successful based on the predicted outcomes of their clinical trials. The SaaS version of inClinico provides analysts with a validated prediction of the probability of success (PoS) of ongoing clinical trials. It correctly adjusts net present value (NPV) for risk and values companies appropriately with greater returns and lower cost of capital. InClinico leverages proprietary ML algorithms for information extraction and data harmonization and a large preclinical databank fed from CROs, PandaOmics & Pharmacognitive. Learn more about how your clinical team can get ahead with our platform by visiting our website and requesting a demo!
inClinico的外部链接
Startup?Insilico Medicine?offers a software program called InClinico, which uses #generativeAI to?predict outcomes of Phase II clinical trials, which is the part where initial efficacy is determined. The company says the technology can predict with 79% accuracy how a Phase II trial will play out.?
Nice to see inClinico mentioned - it was a lot of work over many years https://lnkd.in/gNKUVu7h
inClinico转发了
Nice to see inClinico mentioned - it was a lot of work over many years https://lnkd.in/gNKUVu7h
inClinico转发了
Senior Business Development Manager at Insilico Medicine | Accelerating drug discovery and development with AI & robotics ??
?? Did you know Malm? is famous for having the BEST falafels in Sweden? Well, here’s another exciting fact: Insilico Medicine is making our first-ever appearance at #NLSDays2024, and we’re kicking it off with a bang! ?? Petrina Kamya, Ph.D., Global Head of AI Platforms and President of Insilico Medicine Canada, will be part of the opening address panel, "Unveiling the Future: Life Science Industry and Healthcare in the Age of AI," alongside: ? Mala Valroy - Deep Tech Investment Manager, Industrifonden ? Peder Blomgren - VP and Head of Data Office, AstraZeneca ? Claire Riches - VP, Clinical Solutions, Citeline Attending #NLSDays ? Let’s connect in person! Drop a comment or DM me to chat about: ?? our Pharma.AI platforms (PandaOmics, Chemistry42, Generative Biologics, inClinico) and how it can accelerate your drug discovery initiatives ?? our internal assets that are ready for out-licensing (Read more about it here: https://lnkd.in/g5UnVWii) ?? potential collaborations and partnerships Bonus: And, of course, if you're game, let’s grab one of those legendary Malm? falafels together! ???? Not attending? No problem—DM me to schedule a virtual meeting ?? Looking forward to meeting both familiar faces and new ones— Nordic Life Science Days will be epic! ?? #generativeAI #AI #artificialintelligence #AIDD #drugdiscovery #drugdevelopment #lifesciences #healthcare #networking #InsilicoMedicine #NLSDays #Sweden #Nordics #Malm? ??
inClinico转发了
Senior Business Development Manager at Insilico Medicine | Accelerating drug discovery and development with AI & robotics ??
???? What an epic first day at Aging Research & Drug Discovery Meeting #ARDD2024 ! ?? I've had the pleasure of meeting so many amazing people in the longevity community. If we haven't crossed paths yet, swing by our booth! I'd be happy to show you a live demo of our platforms (PandaOmics , Chemistry42 , inClinico , Precious3GPT ) and chat about how they can supercharge your research. Insilico Medicine Fedor Galkin Stephanie Tsang #ARDD2024 #longevity #agingresearch
inClinico转发了
?? Meet Insilico Medicine’s team at Aging Research & Drug Discovery Meeting! Our team is on-site and ready to showcase the power of our Pharma.AI platform! Join us for live demo where you can explore how our cutting-edge AI technologies are transforming drug discovery and aging research. This is a rare opportunity to connect directly with our experts, try out our platform, and see firsthand how Pharma.AI can accelerate your research. Let’s connect and drive the future of healthcare together! Alex Zhavoronkov Alex Aliper Frank Pun Jan Szollos, MBA Aisyah S. Fedor Galkin Stephanie Tsang PandaOmics Chemistry42 Precious3GPT inClinico #ARDD2024 #InsilicoMedicine #PharmaAI #agingresearch #drugdiscovery #AIinhealthcare
inClinico转发了
Senior Business Development Manager at Insilico Medicine | Accelerating drug discovery and development with AI & robotics ??
?????? In 10 days, Insilico Medicine's Pharma.ai team will be in Copenhagen for the 11th Aging Research & Drug Discovery Meeting ! ?? If you're attending or based in Denmark, let’s connect over fika (my treat! ??) to discuss how you can access our Pharma.ai platforms for internal R&D, or opportunities for collaboration. ?? ??? Send me a DM to set up a time—see you there! ?? Insilico Medicine PandaOmics Chemistry42 Generative Biologics inClinico Jan Szollos, MBA Frank Pun #ARDD2024 #networking #Copenhagen #insilicomedicine
On July 23rd, 2pm EDT in a Virtual Launch Event, Insilico is going to unveil three innovative in-house developed AI products for researchers as well as introduce the updates to https://bit.ly/4f0noIv the company’s proprietary #generativeAI-driven platform for early #drugresearch. In addition, we will introduce our new advanced sustainability initiative driven by AI. The event will include a Q&A session for attendees. Currently, 10 of the world's top 20 #pharmaceutical companies use https://bit.ly/3Y4NzI6 Powered by the platform, Insilico has nominated 18 #preclinical candidates in its comprehensive portfolio of over 30 assets since 2021, and has received IND approval for 7 molecules. Recently, the company published a paper in Nature Biotechnology presenting the entire R&D journey of its lead drug pipeline, INS018_055, from AI algorithms to Phase II #clinicaltrials. “At Insilico, we are committed to continually expanding the boundaries of AI applications and applying them to all aspects of life sciences to accelerate drug discovery, empower anti-aging research, and support sustainable development,” said Alex Zhavoronkov, founder and CEO of Insilico Medicine, “ These new product launches are expected to help life science researchers accomplish their tasks more easily and efficiently. This is the true promise of genAI.” Read the full release here: https://bit.ly/3Y3ozkh
inClinico转发了
New membership offer at Insilico Medicine ? Insilico Medicine is pleased to offer a special discount offer for SwedenBIO members. Insilico Medicine is a pioneer in utilizing generative AI for drug discovery and development and has delivered breakthroughs for healthcare in multiple disease areas, including idiopathicpulmonary fibrosis (IPF), cancer, immunology and aging-related diseases. ? As a member of SwedenBIO, your company and all employees get direct access to an extensive network, knowledge about the industry, a strong voice in the debate and useful offers and discounts. ? Head over to our website to see all member offers: https://lnkd.in/dK8-gwBh inClinico Chemistry42 PandaOmics
inClinico转发了
Senior Business Development Manager at Insilico Medicine | Accelerating drug discovery and development with AI & robotics ??
?? Are you a member of SwedenBIO? ?? If yes, I have exciting news for you! Insilico Medicine, a pioneer in generative AI for drug discovery and development, is gearing up to make waves in the Nordics this year by bringing AI solutions within everyone's reach. How? Well, we're kicking off by rolling out exclusive discounts just for SwedenBIO members! ??PandaOmics:?A 20% discount on PandaOmics, where you can expand your horizons of OMICs data analysis and visualization. ?? ??Chemistry42:?Use generative AI and physics to create small molecules. For purchases of three or more tokens, members receive a 20% discount on Chemistry42. ?? ??For academics, explore our academic grant application: https://lnkd.in/dDtfp_v6 ?? But wait, there's more! If you've got an innovative project that could benefit from our PHARMA.AI platform – whether it's target and biomarker identification, generative drug design, or clinical trial design – let's team up and make magic happen! Drop me a line to explore the endless possibilities. I'm all ears and ready to chat. ?? Alex Zhavoronkov Alex Aliper Petrina Kamya, Ph.D. Jan Szollos, MBA Michelle Chen SwedenBIO AI Sweden Daniel Miller Hugo de Almeida Pouyan Haghshenas Haining Wang Yi-shu Tu Ivan Ozerov Aggie Hsin-I Chen Alisa Liao Life Science Sweden SciLifeLab GoCo Health Innovation City Nordic Life Science Days Stockholm Science City Chalmers School of Entrepreneurship Karolinska Institutet Business Region G?teborg AB EIT Health EIT Health Scandinavia Hadean Ventures Medicon Village Sahlgrenska Science Park SmiLe Venture Hub Smile Incubator Ume? Biotech Incubator #SwedenBIO #GenerativeAI #DrugDiscovery #HealthcareInnovation #PandaOmics #Chemistry42 #InsilicoMedicine #ai #genai #platform
New membership offer at Insilico Medicine ? Insilico Medicine is pleased to offer a special discount offer for SwedenBIO members. Insilico Medicine is a pioneer in utilizing generative AI for drug discovery and development and has delivered breakthroughs for healthcare in multiple disease areas, including idiopathicpulmonary fibrosis (IPF), cancer, immunology and aging-related diseases. ? As a member of SwedenBIO, your company and all employees get direct access to an extensive network, knowledge about the industry, a strong voice in the debate and useful offers and discounts. ? Head over to our website to see all member offers: https://lnkd.in/dK8-gwBh inClinico Chemistry42 PandaOmics
inClinico转发了
Great discussion today at MTIP Basel Healthcare Conference!
Good Morning from the MTIP Basel Healthtech Conference! ??We are amazed to see so many earlybirds from the Healthtech scene with some of you even signing up last night. We are in full swing with our first panel, AI Unleashed: Turbocharging Drug Discovery at Scale by the great Stephen R. Yann Gaston-Mathe, Edoardo Madussi, Gunjan Bhardwaj, Maximilien Levesque and Jan Szollos, MBA. Looking forward to two days of insights, networking and fun! ????? #baselhealthtech #conference #digitalhealth